Metastatic Differentiated Thyroid Cancer Completed Phase 2 Trials for Acetylsalicylic acid (DB00945)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0040042 (Metastatic Differentiated Thyroid Cancer) | Completed | 2 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT00654238 | Phase II Trial of Sorafenib (Nexavar) in Patients With Advanced Thyroid Cancer | Treatment |